We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change to the information provided on adverse events in the Summary of Product Characteristics for Credelio 56mg/ 112mg/ 225mg/ 450mg/ 900mg Chewable Tablets for Dogs
Product recall for two batches of NT Labs Methylene Blue.
Workstream Lead vacancy working on the Synergy Programme.
Product defect recall alert for Revozyn RTU 400 mg/ml Suspension for Injection for Cattle by Dechra on behalf of Eurovet Animal Health B.V.
Change to the information provided on adverse events in the Summary of Product Characteristics for Alizin 30 mg/ml Solution for Injection.
More information following investigation into an increase of adverse event reports following the use of Genta-Equine 100 mg/ml Solution for Injection for Horses.
Cross-Defra Coordinator vacancy working for the Antimicrobial Resistance (AMR) National Action Plan (NAP).
VICH consultation until 31 May 2025 on guideline relating to stability testing for medicated premixes.
We are seeking a Non-Executive Director to join our Management Board and Chair the Audit and Risk Assurance Committee (ARAC).
Policy Officers work on the development and implementation of policy and legislation on veterinary medicines.
Opportunity for veterinary students to apply to attend a one-week extramural studies (EMS) placement in July 2025.
Senior Safety Assessor vacancy, working on authorising veterinary medicines in the UK.
VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia.
Vacancies for Application Co-ordinator roles, working on applications received in respect of veterinary medicine marketing authorisations.
Director Support Office vacancy, working to support our Directors and Senior Colleagues.
Online training event on Wednesday 5 March 2025 ideal for anyone involved in veterinary dispensary roles.
VMD response to concerns raised following media reports of serious adverse events in dogs administered Librela.
Change to the information provided on adverse events in the Summary of Product Characteristics for Meflosyl 5% Solution for Injection, authorised for use in horses.
Increase in suspected adverse event reports following use of Genta-Equine 100 mg/ml Solution for Injection for Horses.
Over 13,000 AbPrazole and Absucralfate products destined for sites across the UK were seized by VMD enforcement officers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).